Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Dual Inhibition of GSK3β and CDK5 Protects the Cytoskeleton of Neurons from Neuroinflammatory-Mediated Degeneration In Vitro and In Vivo.

Reinhardt L, Kordes S, Reinhardt P, Glatza M, Baumann M, Drexler HCA, Menninger S, Zischinsky G, Eickhoff J, Fröb C, Bhattarai P, Arulmozhivarman G, Marrone L, Janosch A, Adachi K, Stehling M, Anderson EN, Abo-Rady M, Bickle M, Pandey UB, Reimer MM, Kizil C, Schöler HR, Nussbaumer P, Klebl B, Sterneckert JL.

Stem Cell Reports. 2019 Jan 31. pii: S2213-6711(19)30017-7. doi: 10.1016/j.stemcr.2019.01.015. [Epub ahead of print]

2.

Gasdermin D plays a vital role in the generation of neutrophil extracellular traps.

Sollberger G, Choidas A, Burn GL, Habenberger P, Di Lucrezia R, Kordes S, Menninger S, Eickhoff J, Nussbaumer P, Klebl B, Krüger R, Herzig A, Zychlinsky A.

Sci Immunol. 2018 Aug 24;3(26). pii: eaar6689. doi: 10.1126/sciimmunol.aar6689.

PMID:
30143555
3.

Processing of Natural Echolocation Sequences in the Inferior Colliculus of Seba's Fruit Eating Bat, Carollia perspicillata.

Beetz MJ, Kordes S, García-Rosales F, Kössl M, Hechavarría JC.

eNeuro. 2017 Dec 13;4(6). pii: ENEURO.0314-17.2017. doi: 10.1523/ENEURO.0314-17.2017. eCollection 2017 Nov-Dec.

4.

Discovery of a Novel Inhibitor of the Hedgehog Signaling Pathway through Cell-based Compound Discovery and Target Prediction.

Kremer L, Schultz-Fademrecht C, Baumann M, Habenberger P, Choidas A, Klebl B, Kordes S, Schöler HR, Sterneckert J, Ziegler S, Schneider G, Waldmann H.

Angew Chem Int Ed Engl. 2017 Oct 9;56(42):13021-13025. doi: 10.1002/anie.201707394. Epub 2017 Sep 18.

PMID:
28833911
5.

Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial.

Kordes S, Pollak MN, Zwinderman AH, Mathôt RA, Weterman MJ, Beeker A, Punt CJ, Richel DJ, Wilmink JW.

Lancet Oncol. 2015 Jul;16(7):839-47. doi: 10.1016/S1470-2045(15)00027-3. Epub 2015 Jun 8.

PMID:
26067687
6.

Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer.

Kordes S, Klümpen HJ, Weterman MJ, Schellens JH, Richel DJ, Wilmink JW.

Cancer Chemother Pharmacol. 2015 Jun;75(6):1135-41. doi: 10.1007/s00280-015-2730-y. Epub 2015 Mar 31.

7.

Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study.

Kordes S, van Berge Henegouwen MI, Hulshof MC, Bergman JJ, van der Vliet HJ, Kapiteijn E, van Laarhoven HW, Richel DJ, Klinkenbijl JH, Meijer SL, Wilmink JW.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):190-6. doi: 10.1016/j.ijrobp.2014.05.022.

PMID:
25195993
8.

Targeted therapy for advanced esophagogastric adenocarcinoma.

Kordes S, Cats A, Meijer SL, van Laarhoven HW.

Crit Rev Oncol Hematol. 2014 Apr;90(1):68-76. doi: 10.1016/j.critrevonc.2013.10.004. Epub 2013 Oct 12. Review.

PMID:
24183912
9.

A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer.

Kordes S, Richel DJ, Klümpen HJ, Weterman MJ, Stevens AJ, Wilmink JW.

Invest New Drugs. 2013 Feb;31(1):85-91. doi: 10.1007/s10637-012-9802-1. Epub 2012 Feb 25.

10.

Investigations into the prevention of neonatal Toxocara canis infections in puppies by application of doramectin to the bitch.

Schnieder T, Kordes S, Epe C, Kuschfeldt S, Stoye M.

Zentralbl Veterinarmed B. 1996 Mar;43(1):35-43.

PMID:
8919967

Supplemental Content

Loading ...
Support Center